京华激光(603607) - 2021 Q1 - 季度财报

Financial Performance - Operating income rose by 35.80% to CNY 186,651,157.64 year-on-year[6] - Net profit attributable to shareholders increased by 14.22% to CNY 23,481,483.04 compared to the same period last year[6] - Basic earnings per share improved by 14.29% to CNY 0.16[6] - Total revenue for Q1 2021 reached ¥186,651,157.64, a 35.8% increase from ¥137,445,418.95 in Q1 2020[30] - Net profit for Q1 2021 was ¥30,785,207.50, compared to ¥27,743,012.90 in Q1 2020, showing a growth of 7.3%[30] - The company's revenue for Q1 2021 was CNY 104,712,601.34, representing a 28.2% increase from CNY 81,696,113.73 in Q1 2020[34] - Net profit for Q1 2021 reached CNY 15,908,740.33, up 25.6% from CNY 12,731,037.83 in Q1 2020[34] - The gross profit margin improved to 29.5% in Q1 2021 compared to 25.8% in Q1 2020[34] Asset and Liability Management - Total assets increased by 4.12% to CNY 1,144,753,111.28 compared to the end of the previous year[6] - Total assets increased to CNY 1,144,753,111.28 from CNY 1,099,422,349.20, indicating overall growth in the company's asset base[20] - Total liabilities increased to ¥200,290,110.25 in Q1 2021 from ¥175,211,538.09 in Q1 2020, reflecting a rise of 14.4%[28] - Shareholders' equity reached ¥795,630,860.24 in Q1 2021, up from ¥780,981,853.44 in Q1 2020, indicating a growth of 1.8%[28] Cash Flow Analysis - Cash flow from operating activities surged by 82.27% to CNY 43,241,985.76 year-on-year[6] - The net cash flow from operating activities for Q1 2021 was ¥46,271,960.06, a significant increase from ¥7,276,736.20 in Q1 2020, representing a growth of approximately 535%[41] - Total cash inflow from operating activities was ¥94,035,321.04, compared to ¥84,996,439.96 in Q1 2020, representing an increase of approximately 10.5%[41] - The total cash outflow from operating activities was ¥47,763,360.98, a decrease from ¥77,719,703.76 in Q1 2020, showing improved cash management[41] Research and Development - Research and development expenses rose by 77.45% to CNY 21,391,451.89 from CNY 12,054,666.94, reflecting increased investment in R&D projects[15] - R&D expenses increased to ¥21,391,451.89 in Q1 2021, up 77.5% from ¥12,054,666.94 in Q1 2020, indicating a focus on innovation[30] - Research and development expenses increased to CNY 10,630,216.91, a 92.5% rise from CNY 5,524,731.44 in Q1 2020[34] Shareholder Information - The number of shareholders reached 11,847 by the end of the reporting period[12] - The largest shareholder, Zhejiang Xingsheng Investment Management Co., Ltd., holds 31.63% of the shares[12] Other Financial Metrics - The weighted average return on equity increased by 0.23 percentage points to 3.09%[6] - The company reported non-recurring gains of CNY 4,839,859.58 during the period[9] - Financial expenses showed a significant negative change of -206.64%, with a net expense of CNY -497,273.87 compared to CNY -162,170.48, mainly due to increased interest from working capital[15] - Operating costs for Q1 2021 were ¥162,050,390.85, up 40.8% from ¥115,047,504.59 in Q1 2020[30] - Gross profit for Q1 2021 was ¥24,600,766.79, compared to ¥22,397,914.36 in Q1 2020, reflecting a gross margin improvement[30]